Variables
|
Odds ratio
|
95% confidence intervals
|
P-value
|
---|
Pretreatment albumin
| | | |
≥35 g/L
|
1.00(ref.)
| | |
<35 g/L
|
0.685
|
0.302-1.550
|
0.363
|
Pretreatment CEA
a
| | | |
<10 ng ml-1
|
1.00(ref.)
| | |
≥10 ng ml-1
|
3.338
|
1.523-7.315
|
0.003
|
Differentiation
| | | |
Well
|
1.00(ref.)
| | |
Moderately
|
1.200
|
0.308-4.678
|
0.793
|
Low
|
3.049
|
0.553-16.828
|
0.201
|
Sex
| | | |
Male
|
1.00(ref.)
| | |
Female
|
1.219
|
0.600-2.474
|
0.584
|
Age
| | | |
≤49 years
|
1.00(ref.)
| | |
50-60 yeas
|
0.840
|
0.271-2.608
|
0.763
|
>60 years
|
2.358
|
0.904-6.154
|
0.080
|
Location
| | | |
Rectum
|
1.00(ref.)
| | |
Left colon cancer
|
1.056
|
0.484-2.300
|
0.892
|
Right colon cancer
|
0.532
|
0.192-1.475
|
0.225
|
Stage
| | | |
II
|
1.00(ref.)
| | |
III
|
0.847
|
0.403-1.781
|
0.661
|
-
a Carcinoembryonic antigen.